A homologous enzymeimmunoassay (EIA) for plasma progesterone, using a horseradish peroxidase conjugate as enzyme label and an antiserum raised against a progesterone-l l or.-hemisuccinyl/BSA conjugate, is described. The antiserum was covalently linked to microcrystalline cellulose to facilitate separation of bound and free steroid; this solid-phase antiserum was stable for at least nine months when stored at 4°C. The freeze-dried enzyme label is also stable, having retained both enzymic and immunological activity for about four years. The EIA developed was specific and had the sensitivity (4'8 pg/tube) required for determining progesterone concentrations in plasma samples collected at any time during the menstrual cycle. EIA of plasma samples provided results which were in good agreement with a well validated radioimmunoassay (RIA). The specificity and inter-and intra-assay coefficients of variation in the EIA were strictly comparable with those of the RIA. The method described has been in use for two years and has been assessed in external quality assurance programmes established by the World Health Organization and the United Kingdom
It is now generally accepted that plasma progesterone concentrations provide clinically useful information regarding ovulation and the formation of a functional corpus luteum. Daily plasma sampling regimens are inconvenient in routine investigations of women attending infertility clinics, and it has been suggested that progesterone concentrations in samples taken at weekly intervals;' or even a single sample in the mid-luteal phase of the menstrual cycle," provides sufficient evidence for ovulation. Despite the widespread use of these restricted sampling regimens studies of female infertility generate large numbers of samples.
Current radioimmunoassays (RIA) featuring liquid-phase antisera and tritiated progesterone as the ligand are not suitable for processing large batches of samples. Counting of the~-emitting isotope requires expensive scintillant and vials, and separation of antibody-bound and free steroid by time-and temperature-dependent procedures such as those involving dextran-coated charcoal and ammonium sulphate limit the number of samples that can be processed in anyone batch. A solidphase enzymeimmunoassay (EIA) for progesterone was therefore developed since such assays are Material and methods Progesterone, bovine adjusted to pH 6·0 with concentrated hydrochloric acid. The alternative substrate, ABTS, was prepared in an acetate-phosphate buffer (0'1 M, pH 5· 0) containing 1· 5 rnrnol/l sodium perborate. All buffers were stored at 4°C; those containing the bacteriostatic agent sodium azide were stored for a maximum of one week whereas those used in the EIA were prepared when required.
ASSESSMENT OF ENZYME ACTIVITY
The activity associated with various concentrations of the 'antibody-bound' enzyme-label was determined using the following procedures.
Substrate I (o-phenylenediamine/Hjffj) o-Phenylenediamine (30 mg) and hydrogen peroxide (20 fll, 30 %wIv) were dissolved in phosphate buffer (100 ml) in an actinic-glass container, this solution being prepared just before use to minimise autoxidation of the amine. The mixture was stirred to ensure complete dissolution of the amine, and 2 ml of this solution was added to all tubes. After incubation of the tubes for 1 hour in the dark at room temperature the enzyme-substrate reaction was terminated by the addition of sulphuric acid (0'6 ml, 4 N). After centrifugation (10 minutes; 1300 g) the colour formed in the supernatant was read at 492 nm in a Gilford 300-N spectrophotometer.
Substrate II (ABTS) ABTS (30 mg) was dissolved in acetate-phosphate buffer (100 mI, 0·1 M, pH 5,0), and 2 ml of this solution was added to all tubes. After incubation (1 hour at RT) the enzyme-substrate reaction was terminated by the addition of ethanol (500 ul), and after centrifugation the colour in the supernatant was read at 420 nm.
Anti-progesterone serum (solid phase)
The immunogen, progesterone-Ll a-hemisuccinate-BSA, was prepared essentially by the method of Kohen et al., 8 and antisera were raised in rabbits following the procedure of Vaitukaitis et al:" The antiserum was BSA-absorbed using the procedure of Thorneycroft et al. 8 and coupled to cyanogen bromide-activated microcrystalline cellulose by a method essentially similar to that of Wide 9 using borate buffer (0'1 M, pH =F 8, 6 ). The solid-phase antiserum was stored at 4°C as a 1/100 dilution in EIA buffer and was stable for at least nine months under these conditions. Titration of the antiserum before and after coupling, using tritiated progesterone as the ligand, indicated that the loss of activity during the coupling procedure was minimal.
Titration of enzyme label
Various masses of enzyme label (2' 5-200 ng) were incubated with solid-phase antiserum in the presence and absence of added progesterone (0--800 pgjtube), the dose response curve for use in the assay being selected from the data generated, which are illustrated in Figure 1 . An enzyme-label concentration of 50 ng/tube was selected as 'optimal' for sensitivity, precision, and 'displacement' at 800 pg of added progesterone.
Enzymeimmunoassay procedure
Aliquots of plasma (30 fll) diluted with deionised water (100 ul) were extracted by shaking mechanically for 10 minutes in a Multi-vortex type shaker with petroleum ether (2 m!) in disposable glass tubes (100 x 12 mm). The aqueous phase was frozen, and the organic solvent was decanted into disposable glass assay tubes (75 x 12 mm). After the solvent had been dried in a stream of nitrogen at 30°C, assay buffer (200 fl!) was added to the steroid residue, and the tubes were briefly mixed on a vortex mixer. Suitably diluted (1/3500) solid-phase antiserum (200 fl!) and enzyme label (100 fll, 50 ng/tube) were added, and the tubes were then incubated overnight at 4°C. After incubation substrate buffer (4 ml) was added, the tubes were centrifuged (1300 g, 10 minutes at 4°C), and the supernatant was decanted. This procedure was then repeated, and after the buffer had been decanted substrate solution was added. The enzyme activit; associated with the 'washed antiserum pellet' was 12 10 determined by the procedure described earlier using substrate I unless otherwise stated.
Dose-response curves were plotted, and the progesterone concentrations in plasma were interpolated using either the log-logit or the Rodbard and Hutt-" four-parameter model. 
Comparison of cross-reactions of structurally related steroids determined by enzymeimmunoassay and radioimmunoassay.
Abraham-s for both the EIA and an RIA, using the conventional dextran-coated charcoal separation procedure. Cross-reactions in the EIA were generally lower than those in the RIA (Table) , a finding in keeping with earlier observations.P 13 As a further test of specificity the results obtained by this EIA were compared with those of an RIA14 in routine use and also with those obtained using a previously published EIA for plasma progesterone featuring a second antibody separation procedure." 
Results
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The lower limit of sensitivity'! in the EIA featuring o-phenylenediamine was 4· 8 pg/assay tube, whereas that using ABTS was 1· 1 pg/assay tube. Replicate assays (n = 30) of high, medium, and low quality control plasma pools (46' 8, 22 '9, and 6·0 nmol/l) established that the inter-and intraassay coefficients (n = 16) of variation were good (Fig. 2) .
The cross-reactivity of various structurally related steroids was assessed according to the criteria of The data illustrated in Fig. 3 indicate good correlations between these procedures. The solid-phase EIA was used to determine plasma progesterone levels in samples collected throughout the menstrual cycle by two normal healthy volunteers. The data illustrated in Fig. 4 show the classically low levels «3 nmol/l) of progesterone in samples collected before ovulation; after ovulation, dated by con-ventional procedures, a sustained rise in progesterone was evident in each case, with peak values between days 18 and 21. Immediately before menses the levels of progesterone feU rapidly to follicular-phase concentrations. Also illustrated in Fig. 4 is an anovulatory cycle (subject HD) showing no rise in plasma progesterone levels throughout the 30·day collection period. mine as the chromogenic substrate has been in use in our laboratory for about two years. During this period it has been monitored by an internal quality control scheme and by external quality assurance programmes in which it has been satisfactory. It therefore appears that although on theoretical grounds RIA may have a slight advantage over EIA, pipetting rather than end-point errors are overriding, and in routine practice well performed EIA and RIA have precisions that are strictly comparable. The comparison of end-point determination time is equally fallacious. In a l00-tube EIA, addition of substrate (3 minutes), incubation (1 hour), centrifugation (20 minutes), and colour measurement manually recorded (10 minutes) take less than 2 hours, whereas in RIA using a tritiated ligand and assuming 2-minute counts, transfer of supernatant (10 minutes), addition of scintillant (5 minutes), capping vials (5 minutes), and radioactivity measurement (3t hours) take over 4 hours. In a busy laboratory, where there are competing demands on counting equipment, the time comparison is likely to be yet more unfavourable to RIA.
Well optimised EIA performs equally as well as the corresponding RIA, but the attainment of such characteristics may require considerable development. A previous communication from these laboratories-" described an EIA for progesterone using antisera coupled to Sepharose 4B. This assay with a sensitivity of 93 pg{tube was adequate to assess induction of ovulation but greater sensitivity (2 pg/tube) was achieved'P using an optimised second antibody precipitation procedure. This accorded with the observation of Comoglio and Celada 22 and Arakawa et al. l D that a liquid-phase separation procedure may increase assay sensitivity. On theoretical grounds it would be expected that all well-optimised separation systems that did not disturb the primary antigen-antibody reaction would give equivalent results at equilibrium, only differences in precision and non-specific binding influencing the overall sensitivity. The differences in reported sensitivity are too great to be attributed to these factors, and so a different solid-phase matrix, microcrystalline cellulose, was investigated. The sensitivity of the new procedure (4'8 pg) compares favourably with that reported previously (2 pg) using a second-antibody separation procedure and the same substrate. Use of this simple, essentially time-and temperature-independent separation technique reo duces errors and imprecision, especially in the hands of less experienced personnel, while substantially reducing the overall assay time compared with the conventional second-antibody procedure.
The assay was further improved by the use of the substrate, ABTS, previously used in a digoxin 'b) Overnll average 10) Enzymeimmunoassays introduced in the early 1970s by Engvall and Perlman'" and van Weemen and Schuurs'" are now recognised to have advantages in assays for biologically active compounds which include absence of radiation hazard, relative stability and low cost of the label, and cheapness and simplicity for servicing of equipment. Suitably optimised EIAs would appear to have comparable precision, sensitivity, and specificity to the corresponding RIAs3 lD 20 although Landon and co-workers-' claim that the additional step of determining enzyme activity prolongs the assay, makes it more complex, and increases imprecision. A truer comparison of the respective merits of EIA and RIA may be made by considering long-term quality control data. The EIA using o-phenylenedia-The EIA reported here has been in routine use for about two years, during which time quality controls from both the WHO and DHSS external quality assurance schemes have been assayed. Overall interassay precision in the WHO scheme was 5 % (n = 12) with an overall negative bias of 14% from the group mean. The inter-assay precision and the variance index scores (VIS) achieved using this EIA when compared with the data generated by other participating laboratories using conventional RIA procedures indicate that the EIA (Fig. 5 ) was ranked 8/28 laboratories on precision and 3/30 on the basis of VIS.16 EIA, 23 the greater stability of this chromogenic reagent reducing the apparent non-specific binding while improving precision and thus the sensitivity (1,1 pgjtube) of this solid-phase technique. In conclusion, a simple robust EIA for plasma progesterone has been established and shown by the usual criteria, including long-term external quality assurance data, to be equally as sensitive, specific, and precise as the corresponding RIA. The minimal demands on equipment and technical expertise make this assay well suited for use in laboratories processing the large numbers of samples generated by investigations of female infertility.
